Although cancer cells are dependent on estrogen for growth, women with ER-positive cancers have better outcomes if they lack a progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) receptors (ER+/PR−/HER2−). Here, ESR1 is linked to cancer.